Dexmedetomidine reduces postoperative cognitive and behavioral dysfunction in adults submitted to general anesthesia for non-cardiac surgery: meta-analysis of randomized clinical trials

Carregando...
Imagem de Miniatura
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
Sociedade Brasileira de Anestesiologia (SBA)
Autores
GOVêIA, Catia Sousa
MIRANDA, Denismar Borges de
OLIVEIRA, Lucas Valente de Brito
PRAXEDES, Felícia Benevides
MOREIRA, Larissa Govêia
Citação
BRAZILIAN JOURNAL OF ANESTHESIOLOGY, v.71, n.4, p.413-420, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Abstract Introduction and objectives Dexmedetomidine (DEX) has been associated with a decrease in postoperative cognitive and behavioral dysfunction in patients submitted to general anesthesia, whether inhalation or total intravenous anesthesia. Consequently, the DEX effects on postoperative agitation and delirium in patients submitted to general anesthesia for non-cardiac surgery have been investigated. Method A systematic review and meta-analysis of randomized and double-blind clinical trials (RCTs) was undertaken assessing adults submitted to elective procedures under general anesthesia receiving DEX or placebo. The search included articles published in English in the Pubmed and Web of Science databases using keywords such as dexmedetomidine, delirium, and agitation. Duplicate publications, studies involving cardiac surgery or using active control (other than saline solution) were included. A random effects model was adopted using the DerSimonian-Laird method and estimate of Odds Ratio (OR) for dichotomous variables, and weighted mean difference for continuous variables, with their respective 95% Confidence Intervals (95% CI). Results Of the 484 articles identified, 15 were selected comprising 2,183 patients (1,079 and 1,104 patients in the DEX and control group, respectively). The administration of DEX was considered a protective factor for postoperative cognitive and behavioral dysfunction (OR = 0.36; 95% CI 0.23-0.57 and p < 0.001), regardless of the anesthesia technique used. Conclusion Dexmedetomidine administration reduced by at least 43% the likelihood of postoperative cognitive and behavioral dysfunction in adult patients submitted to general anesthesia for non-cardiac surgery.
Palavras-chave
Dexmedetomidine, Delirium, Psychomotor agitation, General anesthesia, Meta-analysis
Referências
  1. Aldecoa C, 2017, EUR J ANAESTH, V34, P192, DOI 10.1097/EJA.0000000000000594
  2. BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
  3. Candiotti KA, 2010, ANESTH ANALG, V110, P47, DOI 10.1213/ane.0b013e3181ae0856
  4. Chen WJ, 2015, INT J CLIN EXP MED, V8, P4601
  5. Cooper L, 2011, J CARDIOTHOR VASC AN, V25, P233, DOI 10.1053/j.jvca.2010.06.006
  6. Deiner S, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2017.1505
  7. DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
  8. Ding LL, 2015, INT J CLIN EXP MED, V8, P11388
  9. Duan X, 2018, BRIT J ANAESTH, V121, P384, DOI 10.1016/j.bja.2018.04.046
  10. Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
  11. Fitzpatrick S, 2018, Postoperative cognitive disorders: postoperative delirium and postoperative cognitive dysfunction. Anaesthesia tutorial of the week
  12. Ham SY, 2014, ACTA ANAESTH SCAND, V58, P955, DOI 10.1111/aas.12379
  13. Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
  14. Iamaroon A, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-1449-8
  15. Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321
  16. Janssen TL, 2019, CLIN INTERV AGING, V14, P1095, DOI 10.2147/CIA.S201323
  17. Kim DJ, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0127-4
  18. Kim SY, 2013, BRIT J ANAESTH, V111, P222, DOI 10.1093/bja/aet056
  19. Kwon SY, 2016, J KOREAN MED SCI, V31, P125, DOI 10.3346/jkms.2016.31.1.125
  20. Lee C, 2018, J CLIN ANESTH, V47, P27, DOI 10.1016/j.jclinane.2018.03.007
  21. Lee SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002854
  22. Li Y, 2016, ANESTH ANALG, V122, P1202, DOI 10.1213/ANE.0000000000001165
  23. Lin TF, 2009, BRIT J ANAESTH, V102, P117, DOI 10.1093/bja/aen320
  24. Liu YZ, 2016, AGING CLIN EXP RES, V28, P729, DOI 10.1007/s40520-015-0492-3
  25. Moher D, 2010, INT J SURG, V8, P336, DOI [10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007, 10.1371/journal.pmed.1000097, 10.1136/bmj.c869]
  26. Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0
  27. Moshiri E, 2016, ANN CARD ANAESTH, V19, P263, DOI 10.4103/0971-9784.179618
  28. Muller A, 2016, CURR OPIN CRIT CARE, V22, P406, DOI 10.1097/MCC.0000000000000327
  29. Ng KT, 2019, ANAESTHESIA, V74, P380, DOI 10.1111/anae.14472
  30. Scheinin H, 1998, ANESTHESIOLOGY, V89, P574, DOI 10.1097/00000542-199809000-00005
  31. Schenning Katie J, 2015, Anesthesiol Clin, V33, P505, DOI 10.1016/j.anclin.2015.05.007
  32. Shehabi Y, 2009, ANESTHESIOLOGY, V111, P1075, DOI 10.1097/ALN.0b013e3181b6a783
  33. Singh R, 2012, INDIAN J ANAESTH, V56, P156, DOI 10.4103/0019-5049.96325
  34. Amorim Marco Aurélio Soares, 2017, Rev. Bras. Anestesiol., V67, P193, DOI [10.1016/j.bjane.2016.02.007, 10.1016/j.bjan.2016.02.015]
  35. Song J, 2016, J NEUROSURG ANESTH, V28, P14, DOI 10.1097/ANA.0000000000000190
  36. Su X, 2016, LANCET, DOI 10.HTTPS://D0I.0RG/10.1016/S0140-6736(16)30580-3
  37. Sun YY, 2019, DRUG DES DEV THER, V13, P2911, DOI 10.2147/DDDT.S208703
  38. Tang CL, 2018, NEURAL REGEN RES, V13, P280, DOI 10.4103/1673-5374.226399
  39. Villela Nivaldo Ribeiro, 2003, Rev. Bras. Anestesiol., V53, P97, DOI 10.1590/S0034-70942003000100013
  40. Vlajkovic GP, 2007, ANESTH ANALG, V104, P84, DOI 10.1213/01.ane.0000250914.91881.a8
  41. Wells LT, 1999, ANESTH ANALG, V88, P1308, DOI 10.1097/00000539-199906000-00020
  42. Yang XD, 2015, J ORAL MAXIL SURG, V73, P1065, DOI 10.1016/j.joms.2015.01.011
  43. 2014, Diretrizes metodológicas: sistema GRADE - Manual de graduação da qualidade da evidência e força de recomendação para tomada dedecisão em saúde, P72